Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • iSpecimen's Net Cash Flow rose 64933.49% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 20647.04%. This contributed to the annual value of -$465258.0 for FY2024, which is 9641.14% up from last year.
  • Per iSpecimen's latest filing, its Net Cash Flow stood at $2.2 million for Q3 2025, which was up 64933.49% from -$192234.0 recorded in Q2 2025.
  • iSpecimen's 5-year Net Cash Flow high stood at $17.9 million for Q4 2021, and its period low was -$11.5 million during Q1 2023.
  • Its 5-year average for Net Cash Flow is -$742706.0, with a median of -$399389.0 in 2024.
  • Examining YoY changes over the last 5 years, iSpecimen's Net Cash Flow showed a top increase of 696785.53% in 2021 and a maximum decrease of 88848.22% in 2021.
  • Over the past 5 years, iSpecimen's Net Cash Flow (Quarter) stood at $17.9 million in 2021, then tumbled by 129.8% to -$5.3 million in 2022, then surged by 92.94% to -$377902.0 in 2023, then surged by 133.49% to $126554.0 in 2024, then surged by 1633.63% to $2.2 million in 2025.
  • Its Net Cash Flow stands at $2.2 million for Q3 2025, versus -$192234.0 for Q2 2025 and -$1.1 million for Q1 2025.